Sosei Co., Ltd. In-License Urology Drug From Otsuka Pharmaceutical Co., Ltd.
10/19/2005 5:12:48 PM
More...
|
Otsuka Pharmaceutical Co., Ltd. , Galenea Conclude Collaborate Research And Licensing Agreement
10/19/2005 5:12:45 PM
More...
|
Galenea Signs Collaboration And License Agreement With Otsuka Pharmaceutical Co., Ltd.
10/19/2005 5:12:44 PM
More...
|
Otsuka Pharmaceutical Co., Ltd. Grants Exclusive Rights To Develop And Market Rebamipide To Novartis Pharma AG (NVS)
10/19/2005 5:12:39 PM
More...
|
Novartis Pharma AG (NVS) Obtains Rights From Otsuka Pharmaceutical Co., Ltd. To Develop New Treatment For Dry Eye
10/19/2005 5:12:38 PM
More...
|
Otsuka And Prasco Laboratories Sign A Commercial Supply Agreement For PLETAL Tablets
10/19/2005 5:11:51 PM
More...
|
Bristol-Myers Squibb Company (BMY) And Otsuka Pharmaceutical Co., Ltd. Release: ABILIFY(R) (aripiprazole) Approved For Marketing In Europe For The Treatment Of Schizophrenia
10/19/2005 5:11:37 PM
More...
|
Otsuka Pharmaceuticals UK Ltd Selects Britannia Pharmaceuticals Limited To Distribute Adacolumn In The United Kingdom; Novel Treatment For Inflammatory Related Diseases Provides A Significant Alternative To Other Pharmaceutical Therapies
10/19/2005 5:10:55 PM
More...
|
Otsuka Pharmaceutical Co., Ltd.'s Antipsychotic Medication Approved For Marketing In Europe
10/19/2005 5:08:42 PM
More...
|